AN2 Therapeutics
ANTX
ANTX
36 hedge funds and large institutions have $8.78M invested in AN2 Therapeutics in 2025 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
55% less capital invested
Capital invested by funds: $19.5M → $8.78M (-$10.7M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
36
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$577K | |
| 2 | +$525K | |
| 3 | +$189K | |
| 4 |
AC
Almitas Capital
Santa Monica,
California
|
+$122K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$48K |
Top Sellers
| 1 | -$7.82M | |
| 2 | -$1.36M | |
| 3 | -$553K | |
| 4 |
Two Sigma Advisers
New York
|
-$186K |
| 5 |
Two Sigma Investments
New York
|
-$112K |
